• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

303.8700 USD 4.2000 1.40%

As of 17:20:00 ET on 11/26/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 299.8800 High - Low: 303.8700 - 299.4000 Primary Exchange: NASDAQ GM
Volume: 824,599 52-Week Range: 207.4800 - 303.8700 Beta vs XNBI: 0.9999

ETF Chart for IBB

No chart data available.
  • IBB:US 303.5100
  • 1D
  • 1M
  • 1Y
299.6700
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE / RENE CASIS
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-11-25) 299.5500
Assets (M) (on 2014-11-25) 6,380.4980
Shares out (M) 21.30
Market Cap (M) 6,472.43
% Premium 0.04
Average 52-Week % Premium 0.0050
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.15%

Performance for IBB

1-Month +3.77% 1-Year +34.74%
3-Month +9.94% 3-Year +46.63%
Year To Date +32.21% 5-Year +30.84%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 11/25/2014
Name Position Value % of Total
Celgene Corp 4,976,119 552,697,537 8.685%
Amgen Inc 3,392,377 550,379,244 8.648%
Regeneron Pharmaceuticals Inc 1,172,814 484,372,182 7.611%
Gilead Sciences Inc 4,395,175 444,396,144 6.983%
Biogen Idec Inc 1,378,365 420,952,671 6.614%
Vertex Pharmaceuticals Inc 2,526,689 288,522,617 4.534%
Mylan Inc/PA 4,839,387 271,828,368 4.271%
Alexion Pharmaceuticals Inc 1,396,559 269,214,678 4.230%
Illumina Inc 1,318,164 249,409,810 3.919%
BioMarin Pharmaceutical Inc 1,903,444 170,263,066 2.675%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil